Clinical Trials Directory

Trials / Completed

CompletedNCT04773119

AF Burden and Echo-guided Persistent AF Ablation Strategy Using Either PV Isolation Alone (CLOSE Protocol) or Optimized Compartmentalization of the Left Atrium (Pseudo-maze Technique)

AF Burden and Echo-guided Persistent AF Ablation Strategy Using Either PV Isolation Alone (CLOSE Protocol) or Optimized Compartmentalization of the Left Atrium (Pseudo-maze Technique): the CLOSEMAZE Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
62 (actual)
Sponsor
AZ Sint-Jan AV · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Recent publications suggest that neither empirical nor individualized substrate modification strategies could improve single-procedure efficacy beyond pulmonary vein (PV) isolation for persistent atrial fibrillation (AF). However, persistent AF represent a broad spectrum of the same disease and if PV isolation may be sufficient for some patient with self-terminated AF or with a small left atrium, a more extended substrate ablation may be required for other patients, for which a second procedure for atrial tachycardia (AT) recurrence is then frequently needed. In addition, a lot of progress has recently been made in the field of ablation techniques using contiguous and optimized ablation radiofrequency (RF) lesions and also for AT mapping with promising results using repetitive but discontinuous Holter monitoring. This trial aims at 1. To objectively compare atrial tachyarrhythmia (ATA) burden \> 2 months before ablation and after one or two 'CLOSEMAZE'-guided ablation(s) using continuous monitoring and echo data as a guide for the ablation strategy during the first ablation. 2. To assess ATA burden using continuous monitoring up to 3 years after ablation. 3. To identify baseline structural and electrical properties of the atria or procedural characteristics that predict 1-year and 3-year outcome.

Conditions

Interventions

TypeNameDescription
PROCEDUREPVI onlyPatients in this group receive PVI only
PROCEDUREPVI with substrate ablationPatients in this group receive PVI as well as substrate ablation

Timeline

Start date
2018-10-10
Primary completion
2024-07-29
Completion
2024-07-29
First posted
2021-02-26
Last updated
2025-04-22

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04773119. Inclusion in this directory is not an endorsement.